South Africa had first raised the alarm about the new fast-spreading coronavirus variant racing around the world. The company has said its vaccine is effective in generating an immune response against the Omicron variant, according to early data. (https://reut.rs/3yHnJLr)The two-dose, protein-based vaccine has so far got authorizations from European Union regulators and the World Health Organization. For one thing, the bulk of early Omicron infections were in young people, who are less likely to get seriously ill with all versions of the virus. Coronavirus infections start in the nose or possibly the mouth and spread down the throat.

Source: New York Times January 04, 2022 10:15 UTC